Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 5/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.42 |
| ▸ | HTR2B | P41595 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.42 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.42 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.42 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7262436 | 0.91 | TSHR (0.47) | GABRA1LMNAGABRB1GABRB2TSHR | |
| SCHEMBL1487336 | 0.82 | GABRA1 (0.50) | GABRA1LMNAGABRB1GABRB2TSHR | |
| SCHEMBL30411767 | 0.82 | GABRA1 (0.50) | GABRA1LMNAGABRB1GABRB2TSHR | |
| SCHEMBL29477985 | 0.80 | GABRA1 (0.48) | GABRA1LMNAGABRB1GABRB2TSHR | |
| Potassium SCHEMBL30893108 | 0.80 | GABRA1 (0.48) | GABRA1LMNAGABRB1GABRB2TSHR | |
| SCHEMBL9643710 | 0.79 | TSHR (0.47) | GABRA1LMNAGABRB1GABRB2TSHR | |
| SCHEMBL21767240 | 0.78 | TSHR (0.54) | GABRA1LMNAGABRB1GABRB2TSHR | |
| SCHEMBL1494556 | 0.75 | GABRA1 (0.56) | GABRA1LMNAGABRB1GABRB2TSHR | |
| SCHEMBL10779462 | 0.75 | TSHR (0.45) | TSHRPTGS1HPGDCYP1A2CYP3A4 | |
| SCHEMBL311660 | 0.74 | TYR (0.38) | TSHRALDH1A1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120283335-A1 | Analogs of Propofol, Preparation Thereof and Use as Anesthetics | SIGNATURE THERAPEUTICS, INC. | 2012-11-08 | — | — | US | disclosed |
| WO-2009140275-A1 | ANALOGS OF PROPOFOL, PREPARATION THEREOF AND USE AS ANESTHETICS | PHARMACOFORE, INC. (US) | 2009-11-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120283335-A1 | Analogs of Propofol, Preparation Thereof and Use as Anesthetics | GABRP, CYP4F11, CYP2F1 | GABRA1 14/4885LMNA 1435/4885GABRB1 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.